100profile quality
Lampsy Health is a non-wearable, room-based home epilepsy monitor that detects convulsive seizures with over 99% accuracy and alerts caregivers immediately.
Value proposition
"Life with epilepsy, made safer. Get Notified Right Away Review Video Clips Regain Peace of Mind" [1]
Where it wins
- Distinguishes convulsive seizures from everyday movements with >99% accuracy and 0.05 false alarms per day [1].
- Non-wearable, room-based monitoring eliminates the friction and compliance issues of skin sensors or wearables [1].
- Provides immediate alerts and automatic video recordings for post-event review, reducing caregiver anxiety [1].
- Developed with neurologists and validated by leading European hospitals, ensuring clinical reliability [1].
Credibility: Directly from the Lampsy Health homepage, which details the device's accuracy metrics, non-wearable nature, and clinical validation [1].
Business model
- Direct-to-Consumer (DTC) Hardware: Selling a proprietary, non-wearable sensor device directly to families via their website [1].
- Software-Enabled Monitoring: Providing a companion app for real-time alerts and historical video review, creating a sticky ecosystem [1].
- Clinical Validation as a Moat: Leveraging published scientific results and hospital partnerships to build trust and differentiate from consumer-grade wearables [1].
- Award-Winning Innovation: Using recognitions like WIRED 100 and Epilepsy Foundation Accelerator to drive brand awareness and credibility [1].
Credibility: The homepage outlines the 3-step process (Place, Live, Alert), mentions the app, and highlights clinical validation and awards [1].
Competitive landscape
- Wearable Monitors (e.g., Embrace2): Require patient compliance and skin contact, which Lampsy avoids [1].
- Camera-Based Systems: Often raise privacy concerns and lack clinical validation, whereas Lampsy is hospital-validated [1].
- Traditional Monitoring: Relies on human observation, which is inconsistent and labor-intensive [1].
- Differentiators: Lampsy wins on non-wearable convenience, >99% accuracy, clinical validation, and immediate video evidence [1].
Credibility: The homepage contrasts Lampsy with "everyday movements" and "wearables," highlighting its unique value [1].
Market pains
- Caregiver Anxiety: Constant worry and "hovering" over patients with epilepsy [1].
- False Alarms: High false-positive rates in existing monitoring solutions leading to alert fatigue [1].
- Wearable Friction: Patients refusing to wear or forgetting to charge traditional seizure monitors [1].
- Lack of Objective Data: Difficulty for neurologists to get accurate, real-world seizure data [1].
Credibility: The homepage addresses "hovering," "false alarms," and the need for "accuracy" [1].
Strategic implications
Lampsy's non-wearable, room-based approach is a significant differentiator in a market dominated by wearables, addressing compliance and convenience. The clinical validation and hospital partnerships provide a strong moat against consumer-grade competitors. The main risk is scaling hardware manufacturing and ensuring consistent accuracy across diverse home environments. The next signal to watch is adoption by neurologists and insurance providers, which would validate the clinical and economic value of the device.
Improvement suggestions
Publish specific pricing tiers or a "Request a Demo" option to reduce friction for B2B buyers. Expand the clinical validation section with specific study results or quotes from neurologists to further build trust. Explore partnerships with home care agencies and insurance providers to drive bulk adoption. Develop a clear data privacy and security section to address potential concerns about room monitoring.